{"id":118231,"date":"2020-05-13T11:04:36","date_gmt":"2020-05-13T21:04:36","guid":{"rendered":"https:\/\/www.hawaii.edu\/news\/?p=118231"},"modified":"2020-05-13T11:04:36","modified_gmt":"2020-05-13T21:04:36","slug":"medicare-part-d-hiv-patients","status":"publish","type":"post","link":"https:\/\/www.hawaii.edu\/news\/2020\/05\/13\/medicare-part-d-hiv-patients\/","title":{"rendered":"Study calls for Medicare Part D revisions for HIV<\/abbr>"},"content":{"rendered":"Reading time: <\/span> < 1<\/span> minute<\/span><\/span>
\"\"
John A. Burns School of Medicine<\/figcaption><\/figure>\n

A new study led by University of Â鶹´«Ã½<\/span> at M\u0101noa Professor Chien-Wen Tseng<\/strong> proposes the Medicare prescription drug benefit (Part D) cost sharing of HIV<\/abbr> medications be revised. The burden of drug costs for antiretroviral therapy (ART<\/abbr>) and preexposure prophylaxis (PrEP<\/abbr>) treatments primarily falls on patients and is not conducive to achieving the federal 2030 goals for Ending the HIV<\/abbr> Epidemic: A Plan for America (EHE<\/abbr>). The study was published in the Journal of the American Medical Association<\/a><\/em> on April 14. <\/p>\n

\"Photo
Chien-Wen Tseng<\/figcaption><\/figure>\n

Tseng is with the John A. Burns School of Medicine<\/a> Department of Family Medicine and Community Health and is the Hawaii Medical Service Association Endowed Chair in Health Services and Quality Research and is a member of the U.S. Preventive Services Task Force.<\/p>\n

In 2019, President Donald Trump announced a 10-year plan for the EHE<\/abbr> initiative, to be developed by agencies across the U.S.<\/abbr> Department of Health and Human Services.<\/p>\n

Tseng and her collaborators proposed the Medicare Part D cost sharing of ART<\/abbr> and PrEP<\/abbr> medicines for HIV<\/abbr> patients be redesigned so patient out-of-pocket costs are based in stable dollar terms rather than a changing percentage of drug price. This new design should also include a ceiling for patient out-of-pocket expenses.<\/p>\n

“To the extent that affordability is associated with adherence, these results have important clinical and policy implications; the federal EHE initiative will be successful only if patients have reliable access to HIV<\/abbr> treatment and prevention,” said Tseng. “It seems to be apparent that achieving a 90 percent incidence reduction in HIV<\/abbr> by 2030 will require legislation to manage the price of these drugs.” <\/p>\n

Read more on the JABSOM website.<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"

The revisions will help meet federal 2030 goals for Ending the HIV<\/abbr> Epidemic: A Plan for America.<\/p>\n","protected":false},"author":16,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[30],"tags":[31,1363,158,9],"class_list":["post-118231","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-research","tag-john-a-burns-school-of-medicine","tag-manoa-research","tag-publication","tag-uh-manoa","entry","has-media"],"aioseo_notices":[],"aioseo_head":"\n\t\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\t\n\t\t\n\t\t\n\t\t\n\t\t\n\t\t\n\t\t\n\t\t\n\t\t\n\t\t\n\t\t\n\t\t\n\t\t\n\t\t\n\t\t\n\t\t